Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
MousePheno	wide sternum	FAT4 PDGFRA DCHS1	3.11e-06	5	96	3	MP:0012279
Domain	Cyt_P450_E_grp-I_CYP1	CYP1A1 CYP1A2	4.30e-05	2	123	2	IPR008066
Domain	Tox-GHH_dom	TENM3 TENM1	2.56e-04	4	123	2	IPR028916
Domain	Tox-GHH	TENM3 TENM1	2.56e-04	4	123	2	PF15636
Domain	Ten_N	TENM3 TENM1	2.56e-04	4	123	2	IPR009471
Domain	Ten_N	TENM3 TENM1	2.56e-04	4	123	2	PF06484
Domain	TENEURIN_N	TENM3 TENM1	2.56e-04	4	123	2	PS51361
Domain	EGF_1	FAT4 RELN LAMA5 MUC12 ITGB5 TENM3 VCAN TENM1	2.88e-04	255	123	8	PS00022
Domain	EGF-like_CS	FAT4 RELN LAMA5 MUC12 ITGB5 TENM3 VCAN TENM1	3.37e-04	261	123	8	IPR013032
Domain	EGF_2	FAT4 RELN LAMA5 MUC12 ITGB5 TENM3 VCAN TENM1	3.73e-04	265	123	8	PS01186
Domain	YD	TENM3 TENM1	4.25e-04	5	123	2	IPR006530
Domain	FAD_binding_1	NDOR1 MTRR	6.34e-04	6	123	2	PF00667
Domain	-	NDOR1 MTRR	6.34e-04	6	123	2	1.20.990.10
Domain	FAD-binding_1	NDOR1 MTRR	6.34e-04	6	123	2	IPR003097
Domain	NADPH_Cyt_P450_Rdtase_dom3	NDOR1 MTRR	6.34e-04	6	123	2	IPR023173
Domain	EGF_extracell	RELN ITGB5 TENM3 TENM1	6.57e-04	60	123	4	IPR013111
Domain	EGF_2	RELN ITGB5 TENM3 TENM1	6.57e-04	60	123	4	PF07974
Pathway	WP_ESTROGEN_METABOLISM_WP697	CYP1A1 CYP1A2 UGT1A6 ARSL	3.70e-06	18	86	4	M39424
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC12 MUC6	1.16e-04	16	86	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC12 MUC6	1.40e-04	17	86	3	M27412
Pubmed	Defining the membrane proteome of NK cells.	EPS15 GAK PDGFRA LSG1 AKNA DGKA IFI16 BIRC6 F5 ANKRD27 PRDX6 NBAS AAAS GANAB KIDINS220 HPS6 TMPO PRKDC EIF3F EIF2AK3	9.49e-09	1168	127	20	19946888
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NDOR1 SETD1B DUSP5 AKNA LAMA5 TESK1 BIRC6 ITGB5 MADD PLEKHH3 SBNO2 MAPK8IP3 MST1R WIZ TTLL4 HPS6 TANC1 PRKDC CABIN1	2.17e-08	1105	127	19	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PDGFRA KIF26B LSG1 SPECC1 TESK1 VIRMA ANKRD27 MADD ZNF106 BMPR2 ALMS1 SYNE2 TET1 NHS TANC1 CRYBG3	1.10e-07	861	127	16	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	VGF TPR EPS15 NHSL2 LSG1 ZNF318 VIRMA MAPK8IP3 WIZ KCNB1 SRGAP3 SYNE2 DCHS1 CABIN1 KCNT1 CDH10	4.89e-07	963	127	16	28671696
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FAT4 MXRA5 KIF26B DGKA BIRC6 IGSF10 ARHGAP5 AFAP1L2 WIZ SRGAP3 MYO3B PCIF1 TMPO PRKDC	5.47e-07	736	127	14	29676528
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	LAMA5 NCKAP5 BIRC6 WAC SCRN2 ZNF106 CCNYL1 TMPO NHS CABIN1	9.61e-07	363	127	10	14691545
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	KIF26B LSG1 KIDINS220 ALMS1 NHS TANC1 CRYBG3 CEP97	1.08e-06	209	127	8	36779422
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	EPS15 GAK LSG1 CHAF1A BIRC6 MADD NBAS ZNF106 AAAS ALMS1 TTLL4 PRR14L TANC1	3.06e-06	733	127	13	34672954
Pubmed	TGFB1 induces fetal reprogramming and enhances intestinal regeneration.	NDOR1 PDGFRA PRKDC	3.93e-06	9	127	3	37865088
Pubmed	Polymorphisms in phase I and phase II metabolism genes and risk of chronic benzene poisoning in a Chinese occupational population.	CYP1A1 CYP1A2 UGT1A6	5.60e-06	10	127	3	18784359
Pubmed	Recombination suppression by heterozygous Robertsonian chromosomes in the mouse.	RELN SGK3 MLPH	5.60e-06	10	127	3	8454207
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	KIAA1549 ZNF318 KIDINS220 ALMS1 TENM1 NHS TANC1 CRYBG3	5.93e-06	263	127	8	34702444
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	TPR SETD1B PDGFRA CHAF1A MUC12 BIRC6 VIRMA INO80D ITGB5 WAC SCRN2 NBAS ZNF106 AAAS GANAB NHS MTO1	7.06e-06	1327	127	17	32694731
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	GAK RUSC1 TESK1 ANKRD27 AAAS KIDINS220 WIZ TMPO	1.06e-05	285	127	8	34369648
Pubmed	Methylation differences in the murine P1450 and P3450 genes in wild-type and mutant hepatoma cell culture.	CYP1A1 CYP1A2	1.32e-05	2	127	2	2425809
Pubmed	Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.	CYP1A1 CYP1A2	1.32e-05	2	127	2	3000715
Pubmed	Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone.	CYP1A1 CYP1A2	1.32e-05	2	127	2	12147246
Pubmed	Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.	CYP1A1 CYP1A2	1.32e-05	2	127	2	17852022
Pubmed	Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.	CYP1A1 CYP1A2	1.32e-05	2	127	2	14980704
Pubmed	Immunocytochemical study of cytochrome P450 (1A1/1A2) induction in murine ocular tissues.	CYP1A1 CYP1A2	1.32e-05	2	127	2	7781742
Pubmed	Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.	CYP1A1 CYP1A2	1.32e-05	2	127	2	11207026
Pubmed	Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.	CYP1A1 CYP1A2	1.32e-05	2	127	2	3785172
Pubmed	Assignment of dioxin-inducible cytochrome P-450 gene family to Chinese hamster chromosome 4.	CYP1A1 CYP1A2	1.32e-05	2	127	2	3860967
Pubmed	Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.	CYP1A1 CYP1A2	1.32e-05	2	127	2	16609368
Pubmed	Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria.	CYP1A1 CYP1A2	1.32e-05	2	127	2	15094312
Pubmed	The RON receptor tyrosine kinase regulates IFN-gamma production and responses in innate immunity.	IFNGR1 MST1R	1.32e-05	2	127	2	18684919
Pubmed	PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation.	BMPR2 EIF2AK3	1.32e-05	2	127	2	33500333
Pubmed	CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.	CYP1A1 CYP1A2	1.32e-05	2	127	2	19285097
Pubmed	[Association of polymorph variants of CYP1A2 and CYP1A1 genes with reproductive and thyroid diseases in female workers of petrochemical industry].	CYP1A1 CYP1A2	1.32e-05	2	127	2	22855999
Pubmed	Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.	CYP1A1 CYP1A2	1.32e-05	2	127	2	12438513
Pubmed	Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.	MST1R PRKDC	1.32e-05	2	127	2	23612011
Pubmed	Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line.	CYP1A1 CYP1A2	1.32e-05	2	127	2	21262253
Pubmed	The nuclear factor of activated T cells 5 (NFAT5) contributes to the renal corticomedullary differences in gene expression.	NDOR1 NFAT5	1.32e-05	2	127	2	36433977
Pubmed	Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells.	CYP1A1 CYP1A2	1.32e-05	2	127	2	26953171
Pubmed	Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition.	CYP1A1 CYP1A2	1.32e-05	2	127	2	18493746
Pubmed	Polycyclic Aromatic Hydrocarbon-induced Pulmonary Carcinogenesis in Cytochrome P450 (CYP)1A1- and 1A2-Null Mice: Roles of CYP1A1 and CYP1A2.	CYP1A1 CYP1A2	1.32e-05	2	127	2	32726451
Pubmed	A shuffled CYP1A library shows both structural integrity and functional diversity.	CYP1A1 CYP1A2	1.32e-05	2	127	2	17823232
Pubmed	Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes.	CYP1A1 CYP1A2	1.32e-05	2	127	2	3988744
Pubmed	CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures.	CYP1A1 CYP1A2	1.32e-05	2	127	2	26643992
Pubmed	Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions.	FAT4 DCHS1	1.32e-05	2	127	2	25355906
Pubmed	PERK is required in the adult pancreas and is essential for maintenance of glucose homeostasis.	NDOR1 EIF2AK3	1.32e-05	2	127	2	23071091
Pubmed	Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.	CYP1A1 CYP1A2	1.32e-05	2	127	2	22949628
Pubmed	Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity.	CYP1A1 CYP1A2	1.32e-05	2	127	2	9295056
Pubmed	Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury.	CYP1A1 CYP1A2	1.32e-05	2	127	2	25680282
Pubmed	Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A.	CYP1A1 CYP1A2	1.32e-05	2	127	2	25703676
Pubmed	Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes.	CYP1A1 CYP1A2	1.32e-05	2	127	2	4054433
Pubmed	Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.	CYP1A1 CYP1A2	1.32e-05	2	127	2	31147315
Pubmed	Aryl hydrocarbon (Ah) receptor-independent induction of Cyp1a2 gene expression by acenaphthylene and related compounds in B6C3F1 mice.	CYP1A1 CYP1A2	1.32e-05	2	127	2	8001243
Pubmed	Metabolism of 4-n-nonylphenol by non-modified and CYP1A1- and CYP1A2-transgenic cell cultures of tobacco.	CYP1A1 CYP1A2	1.32e-05	2	127	2	16402549
Pubmed	The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.	CYP1A1 CYP1A2	1.32e-05	2	127	2	24443269
Pubmed	Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: differential regulation in primary human hepatocytes versus transformed human cells.	CYP1A1 CYP1A2	1.32e-05	2	127	2	16426572
Pubmed	The influence of CYP1A1 and CYP1A2 polymorphisms on stroke risk in the Chinese population.	CYP1A1 CYP1A2	1.32e-05	2	127	2	33046100
Pubmed	IL16 and factor V gene variations are associated with asparaginase-related thrombosis in childhood acute lymphoblastic leukemia patients.	IL16 F5	1.32e-05	2	127	2	36946317
Pubmed	CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.	CYP1A1 CYP1A2	1.32e-05	2	127	2	19276377
Pubmed	A Mutation in Syne2 Causes Early Retinal Defects in Photoreceptors, Secondary Neurons, and Müller Glia.	IFNGR1 SYNE2	1.32e-05	2	127	2	26066746
Pubmed	Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).	CYP1A1 CYP1A2	1.32e-05	2	127	2	17052995
Pubmed	Differences in regulation of gene expression between Cyp1a-1 and Cyp1a-2 in adult mouse hepatocytes in primary culture.	CYP1A1 CYP1A2	1.32e-05	2	127	2	1335375
Pubmed	Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.	CYP1A1 CYP1A2	1.32e-05	2	127	2	8095225
Pubmed	A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes.	CYP1A1 CYP1A2	1.32e-05	2	127	2	16505155
Pubmed	Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.	CYP1A1 CYP1A2	1.32e-05	2	127	2	8274012
Pubmed	Species difference among experimental rodents in induction of P450IA family enzymes by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.	CYP1A1 CYP1A2	1.32e-05	2	127	2	1452456
Pubmed	Structure of the planar cell polarity cadherins Fat4 and Dachsous1.	FAT4 DCHS1	1.32e-05	2	127	2	36797229
Pubmed	Amino-terminal sequence and structure of monoclonal antibody immunopurified cytochromes P-450.	CYP1A1 CYP1A2	1.32e-05	2	127	2	3718958
Pubmed	Balancer-Cre transgenic mouse germ cells direct the incomplete resolution of a tri-loxP-targeted Cyp1a1 allele, producing a conditional knockout allele.	CYP1A1 CYP1A2	1.32e-05	2	127	2	14637164
Pubmed	Comparison of mouse hepatic mitochondrial versus microsomal cytochromes P450 following TCDD treatment.	CYP1A1 CYP1A2	1.32e-05	2	127	2	16516144
Pubmed	Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.	CYP1A1 CYP1A2	1.32e-05	2	127	2	28698457
Pubmed	Mammalian cadherins DCHS1-FAT4 affect functional cerebral architecture.	FAT4 DCHS1	1.32e-05	2	127	2	25930014
Pubmed	[Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].	CYP1A1 CYP1A2	1.32e-05	2	127	2	18389617
Pubmed	Generation of a conditional knockout allele for the NFAT5 gene in mice.	NDOR1 NFAT5	1.32e-05	2	127	2	25601839
Pubmed	Isolation and characterization of full-length mouse cDNA and genomic clones of 3-methylcholanthrene-inducible cytochrome P1-450 and P3-450.	CYP1A1 CYP1A2	1.32e-05	2	127	2	6548461
Pubmed	Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer.	CYP1A1 CYP1A2	1.32e-05	2	127	2	34242741
Pubmed	Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery.	CYP1A1 CYP1A2	1.32e-05	2	127	2	10623596
Pubmed	Rapid induction of colon carcinogenesis in CYP1A-humanized mice by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate.	CYP1A1 CYP1A2	1.32e-05	2	127	2	21081470
Pubmed	Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene-gene and gene-environment interactions for disease susceptibility.	CYP1A1 CYP1A2 UGT1A6	2.10e-05	15	127	3	19575027
Pubmed	Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci.	SGK3 HPS6 MLPH	2.10e-05	15	127	3	6696991
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR EPS15 RUSC1 ZNF318 BIRC6 WIZ ALMS1 TET1 CRYBG3	2.44e-05	418	127	9	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FBF1 AKNA KIAA1549 LAMA5 CLOCK ANKRD27 TTLL4 TET1 ANKIB1 KCNT1	2.60e-05	529	127	10	14621295
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	DUSP5 KIAA1549 BIRC6 MADD ARHGAP5 AAAS GANAB WIZ SYNE2 TMPO SLC39A6 NHS TANC1 CRYBG3	3.10e-05	1049	127	14	27880917
Pubmed	Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development.	FAT4 PDGFRA DCHS1	3.11e-05	17	127	3	32155439
Pubmed	Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.	CYP1A1 CYP1A2 UGT1A6	3.11e-05	17	127	3	19424794
Pubmed	Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.	CYP1A1 CYP1A2 F5 MTRR	3.16e-05	49	127	4	18936436
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC12 MUC6	3.73e-05	18	127	3	18834073
Pubmed	Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.	CYP1A1 CYP1A2	3.96e-05	3	127	2	17997381
Pubmed	Doublefoot: a new mouse mutant affecting development of limbs and head.	SGK3 MLPH	3.96e-05	3	127	2	9062079
Pubmed	CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD.	CYP1A1 CYP1A2	3.96e-05	3	127	2	20080081
Pubmed	Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.	CYP1A1 CYP1A2	3.96e-05	3	127	2	15299091
Pubmed	Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.	A1BG F5	3.96e-05	3	127	2	23690342
Pubmed	Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.	CYP1A1 CYP1A2	3.96e-05	3	127	2	15734958
Pubmed	Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk.	CYP1A1 CYP1A2	3.96e-05	3	127	2	24668907
Pubmed	Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan.	CYP1A1 CYP1A2	3.96e-05	3	127	2	19452301
Pubmed	Meat intake, metabolic genes and colorectal cancer.	CYP1A1 CYP1A2	3.96e-05	3	127	2	12484238
Pubmed	Prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) augments neonatal hyperoxic lung injury: Role of cytochrome P450 (CYP)1A1, 1A2, and 1B1.	CYP1A1 CYP1A2	3.96e-05	3	127	2	38081439
Pubmed	Mitochondrial targeting of cytochrome P450 (CYP) 1B1 and its role in polycyclic aromatic hydrocarbon-induced mitochondrial dysfunction.	CYP1A1 CYP1A2	3.96e-05	3	127	2	24497629
Pubmed	CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.	CYP1A1 CYP1A2	3.96e-05	3	127	2	19666078
Pubmed	Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor.	CYP1A1 CYP1A2	3.96e-05	3	127	2	18814841
Pubmed	Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways.	CYP1A1 CYP1A2	3.96e-05	3	127	2	23956430
Pubmed	Renal Sodium Gradient Orchestrates a Dynamic Antibacterial Defense Zone.	NDOR1 NFAT5	3.96e-05	3	127	2	28803730
Pubmed	Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption.	CYP1A1 CYP1A2	3.96e-05	3	127	2	21357676
Pubmed	FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth.	NDOR1 PRKDC	3.96e-05	3	127	2	32187554
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	3.96e-05	3	127	2	26770020
Interaction	RHOC interactions	FAT4 LSG1 FBF1 SPECC1 ITGB5 IFNGR1 ARHGAP5 BMPR2 AAAS GANAB KIDINS220 SYNE2 TMPO SLC39A6 EIF2AK3	3.42e-06	584	125	15	int:RHOC
Interaction	SYNE3 interactions	GALNT14 GAK FBF1 ZNF318 NBAS AAAS GANAB KIDINS220 ALMS1 SYNE2 CRYBG3 EIF2AK3 CEP97	3.95e-06	444	125	13	int:SYNE3
Interaction	RAC3 interactions	FAT4 KIF26B KIAA1549 SPECC1 IFNGR1 ARHGAP5 BMPR2 AAAS KIDINS220 TENM3 TMPO SLC39A6 NHS TANC1 EIF2AK3	6.91e-06	619	125	15	int:RAC3
Interaction	RND2 interactions	KIF26B KIAA1549 IFNGR1 ARHGAP5 BMPR2 AAAS GANAB KIDINS220 SYNE2 TMPO SLC39A6 EIF2AK3	1.92e-05	440	125	12	int:RND2
Interaction	RND1 interactions	KIF26B KIAA1549 ARHGAP5 BMPR2 GANAB KIDINS220 TMPO SLC39A6 NFAT5	2.32e-05	246	125	9	int:RND1
Interaction	ABTB2 interactions	ZNF318 BIRC6 VIRMA ZNF106 MTO1 CEP97	3.95e-05	101	125	6	int:ABTB2
Interaction	RHOA interactions	FAT4 LSG1 KIAA1549 CLOCK SPECC1 VIRMA PRDX6 IFNGR1 ARHGAP5 BMPR2 AAAS GANAB KIDINS220 TENM3 SYNE2 TMPO SLC39A6 NHS PRKDC EIF2AK3	4.77e-05	1199	125	20	int:RHOA
GeneFamily	CD molecules\|Mucins	MUC16 MUC12 MUC6	1.13e-04	21	82	3	648
GeneFamily	Cytochrome P450 family 1	CYP1A1 CYP1A2	1.21e-04	4	82	2	1000
Coexpression	LEIN_CEREBELLUM_MARKERS	IL16 ARHGAP5 AFAP1L2 SYNE2 SEBOX KCNT1	3.67e-06	85	127	6	M1723
Coexpression	LEIN_CEREBELLUM_MARKERS	IL16 ARHGAP5 AFAP1L2 SYNE2 SEBOX KCNT1	3.67e-06	85	127	6	MM720
Coexpression	HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN	CASS4 FAT4 IL16 NHSL2 SPECC1 ITGB5 SLC47A2 IFNGR1 LDHD VCAN TENM1 FCRLB NHS EIF3F	1.48e-05	740	127	14	M41202
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	BIRC6 ZNF106 BMPR2 SRGAP3 TTLL4 PRR14L NFAT5	2.86e-05	180	127	7	M8239
Coexpression	GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP	THEMIS2 FBF1 IFI16 SPATA1 MYO3B IFI44L HERC6	4.04e-05	190	127	7	M7537
Coexpression	GSE12366_GC_VS_NAIVE_BCELL_DN	IL16 SETD1B DGKA IFI16 INO80D IFNGR1 HERC6	4.77e-05	195	127	7	M3170
Coexpression	GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	CYP1A2 NDOR1 KIF26B ZNF318 CLOCK MAPK8IP3 SYNE2	5.08e-05	197	127	7	M8983
Coexpression	GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	CASS4 GAK INO80D SGK3 ZNF106 PCIF1 NFAT5	5.42e-05	199	127	7	M9498
Coexpression	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP	SPECC1 VIRMA ATP10D PLEKHH3 MST1R MSANTD4 CRYBG3	5.59e-05	200	127	7	M8500
Coexpression	GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP	CYP1A1 DGKA ZNF318 MAPK8IP3 IFNGR1 NBAS TMPO	5.59e-05	200	127	7	M6836
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF GALNT14 RELN KIF26B ITGB5 TENM3 TENM1 NHS	6.74e-08	187	127	8	85f1678338a47d91e296f0620d4887f057eb7e70
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN NHSL2 KIF26B ITGB5 TENM3 TENM1 TANC1	8.94e-08	194	127	8	1bcb3fafd498614f7bac2b1c9b7de56e39110f65
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	GALNT14 ABCA13 KIF26B MARK1 DUSP5 MUC16 NHS	4.65e-07	164	127	7	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 DUSP5 DGKA MUC16 ATP10B SRGAP3 TANC1	8.39e-07	179	127	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 RELN NHSL2 KIF26B F5 TENM3 VCAN	9.03e-07	181	127	7	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 RELN NHSL2 KIF26B F5 TENM3 VCAN	9.03e-07	181	127	7	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 ABCA13 KIAA1549 SLC47A2 SYNE2 TENM1 NHS	9.72e-07	183	127	7	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KIAA1549 NCKAP5 SLC47A2 SYNE2 TENM1 NHS	1.12e-06	187	127	7	dcf6475ece5b34d9d58a0d1f51c18acedb19c119
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KIAA1549 NCKAP5 SLC47A2 SYNE2 TENM1 NHS	1.12e-06	187	127	7	f1356273bd3587b6883295edf15cb9cdb706c057
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	GALNT14 ABCA13 MUC16 PLEKHG4B SRGAP3 NHS MLPH	1.25e-06	190	127	7	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN KIF26B ITGB5 TENM3 TENM1 TANC1	1.39e-06	193	127	7	e74fdc8718fe0933e1f4dd3fe37e2134983b99b6
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN KIF26B ITGB5 TENM3 TENM1 TANC1	1.39e-06	193	127	7	658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	MXRA5 PDGFRA NHSL2 KIF26B TENM3 VCAN NHS	1.59e-06	197	127	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CASS4 FAT4 IL16 KIF26B TENM3 VCAN TANC1	1.59e-06	197	127	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR DGKA ARHGAP5 SYNE2 LPIN2 IFI44L HERC6	1.70e-06	199	127	7	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 IL16 MXRA5 PDGFRA VCAN MYO3B TENM1	1.76e-06	200	127	7	fb53be20392a8309a7393774c774a1b1aec6e676
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 ABCA13 VCAN SYNE2 TENM1 NHS	7.69e-06	164	127	6	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 MXRA5 PDGFRA VCAN TANC1 CRYBG3	9.12e-06	169	127	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR CLOCK IGSF10 ARHGAP5 ZNF106 BMPR2	1.15e-05	176	127	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 RELN KIF26B TENM3 SYNE2 NHS	1.23e-05	178	127	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT14 NCKAP5 SLC47A2 SYNE2 TENM1 NHS	1.31e-05	180	127	6	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A KIAA1549 NCKAP5 IGSF10 VCAN SLC39A6	1.35e-05	181	127	6	4e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A KIAA1549 NCKAP5 IGSF10 VCAN SLC39A6	1.35e-05	181	127	6	ad30c01290fb98adbd0caed301a584761212c977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHAF1A KIAA1549 NCKAP5 IGSF10 VCAN SLC39A6	1.35e-05	181	127	6	3a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SPECC1 F5 LDHD AFAP1L2 MLPH	1.43e-05	183	127	6	876b4f128c2168fdae7488201ff44f19c06c8415
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SPECC1 F5 LDHD AFAP1L2 MLPH	1.43e-05	183	127	6	b190b650e61b1b20baf5e42d04acac82d3fd1400
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	GALNT14 ABCA13 KIAA1549 SLC47A2 SYNE2 NHS	1.48e-05	184	127	6	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	FAT4 PDGFRA ATP10D ZNF106 TENM3 CRYBG3	1.48e-05	184	127	6	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN KIF26B ITGB5 TENM1 NHS	1.48e-05	184	127	6	7f6c8912677764d438ab0555faca344d74c2f483
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDGFRA ATP10B NCKAP5 NSUN7 VCAN TANC1	1.53e-05	185	127	6	efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PDGFRA MARK1 NCKAP5 IGSF10 MLPH	1.53e-05	185	127	6	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDGFRA ATP10B NCKAP5 AFAP1L2 VCAN TANC1	1.53e-05	185	127	6	2e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 RELN NHSL2 KIF26B F5 TENM3	1.53e-05	185	127	6	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PDGFRA MARK1 NCKAP5 IGSF10 MLPH	1.53e-05	185	127	6	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDGFRA ATP10B NCKAP5 AFAP1L2 VCAN TANC1	1.53e-05	185	127	6	7aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PDGFRA MARK1 NCKAP5 IGSF10 MLPH	1.53e-05	185	127	6	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDGFRA ATP10B NCKAP5 NSUN7 VCAN TANC1	1.53e-05	185	127	6	fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 RELN NHSL2 KIF26B F5 TENM3	1.53e-05	185	127	6	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF RELN KIF26B ITGB5 TENM3 TENM1	1.57e-05	186	127	6	96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KIF26B NCKAP5 SLC47A2 SYNE2 NHS	1.57e-05	186	127	6	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THEMIS2 A1BG RELN KIF26B DUSP5 TENM3	1.62e-05	187	127	6	d69f4eee0304a7db226275ab77fc9d5d2b6f3a07
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 ABCA13 MAPK8IP3 SYNE2 TENM1 NHS	1.62e-05	187	127	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	COVID-19-kidney-Mito-rich_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	KIAA1549 NCKAP5 INO80D SLC47A2 SYNE2 NHS	1.62e-05	187	127	6	738ec2611b4be6a08eedad16b57fba84e1f11fef
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DGKA IFI16 SYNE2 LPIN2 IFI44L HERC6	1.67e-05	188	127	6	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KIAA1549 NCKAP5 SLC47A2 TENM1 NHS	1.72e-05	189	127	6	204ab61ae606b2d9be0cb6bf6a83a011740693a8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KIF26B NCKAP5 SLC47A2 LPIN2 NHS	1.72e-05	189	127	6	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 KIAA1549 NCKAP5 SLC47A2 TENM1 NHS	1.72e-05	189	127	6	13fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NCKAP5 SLC47A2 TENM3 VCAN SYNE2 NHS	1.72e-05	189	127	6	28b502611829e4a24caff2562545c7db97686099
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIF26B AKNA TENM3 TENM1 NHS TANC1	1.77e-05	190	127	6	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIF26B TENM3 MYO3B TENM1 NHS TANC1	1.77e-05	190	127	6	0acf1d5da68db449d8c9e70519a236ce825f9d11
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 AFAP1L2 SRGAP3 SLC39A6 NFAT5 MUC6	1.77e-05	190	127	6	078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR SPECC1 ARHGAP5 ZNF106 SYNE2 ANKIB1	1.83e-05	191	127	6	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR SPECC1 ARHGAP5 ZNF106 SYNE2 ANKIB1	1.83e-05	191	127	6	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR SPECC1 ARHGAP5 ZNF106 SYNE2 ANKIB1	1.83e-05	191	127	6	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FAT4 MXRA5 TENM3 SRGAP3 NHS IFI44L	1.88e-05	192	127	6	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PDGFRA KIF26B ITGB5 NHS MSANTD4 TANC1	1.88e-05	192	127	6	c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	RELN MXRA5 PDGFRA KIF26B PLPPR3 TENM3	1.88e-05	192	127	6	d88753b200d9c8da6716222d697ddf0a1548d6c8
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN KIF26B TENM3 TENM1 TANC1	1.94e-05	193	127	6	d1445b8bf2bab36e1a326ddb2a528151db016c7d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VGF GALNT14 RELN KIF26B TENM3 TANC1	1.94e-05	193	127	6	2c15186d15545804cc262da9137ab825609d4b2c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN KIF26B TENM3 TENM1 TANC1	1.94e-05	193	127	6	010717ca052b6c8a525a43aaeffddea0d1113e63
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	CLOCK BIRC6 GANAB PRKDC CRYBG3 CEP97	1.94e-05	193	127	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN KIF26B TENM3 TENM1 TANC1	1.94e-05	193	127	6	2189da4b727e25e62669d7b9257f06493be21a27
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 ABCA13 VCAN SYNE2 NFAT5 MLPH	1.94e-05	193	127	6	0f2167eef8203a5659c8c72e4e77646003d64797
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 RELN KIF26B TENM3 TENM1 TANC1	1.94e-05	193	127	6	3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	MXRA5 PDGFRA NHSL2 KIF26B TENM3 VCAN	1.99e-05	194	127	6	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN KIF26B ITGB5 TENM3 TENM1 TANC1	1.99e-05	194	127	6	83863da11dfbe59b2d0a2c08db40b537c150588c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNT14 KIF26B TENM3 TENM1 NHS TANC1	1.99e-05	194	127	6	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SPECC1 ATP10D TENM3 LPIN2 TANC1	1.99e-05	194	127	6	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A2 LAMA5 NCKAP5 PLEKHG4B ARHGAP5 TANC1	1.99e-05	194	127	6	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA SPECC1 ATP10D TENM3 LPIN2 TANC1	1.99e-05	194	127	6	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT14 ABCA13 ARSL KCNB1 SYNE2 NFAT5	1.99e-05	194	127	6	8ddcaaf24cee6e30d5be52c0cbf778cfba309c53
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A2 LAMA5 NCKAP5 PLEKHG4B ARHGAP5 TANC1	1.99e-05	194	127	6	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 PDGFRA ITGB5 ADGRG4 IGSF10 VCAN	2.05e-05	195	127	6	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	ASK428-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	IL16 MXRA5 PDGFRA IFI16 F5 CCNYL1	2.05e-05	195	127	6	c750602c765a51075ba6ede78e3ba80b62374481
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IFI16 ITGB5 IFNGR1 ARHGAP5 SYNE2 CRYBG3	2.17e-05	197	127	6	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	MXRA5 UGT1A6 LAMA5 SRGAP3 SYNE2 NHS	2.17e-05	197	127	6	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 KIF26B CHAF1A MUC16 SRGAP3 NHS	2.24e-05	198	127	6	28ada093cec552262731194a04a4b9ff93186c3b
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	IL16 PDGFRA NHSL2 KIF26B TENM3 VCAN	2.24e-05	198	127	6	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA13 KIF26B MUC16 PLEKHG4B SRGAP3 NHS	2.24e-05	198	127	6	af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell	mild-CD4+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR DGKA ARHGAP5 SYNE2 LPIN2 IFI44L	2.30e-05	199	127	6	3e4baaf4ee23f257d821194468102c00a8ad2f21
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR SPECC1 INO80D ZNF106 SYNE2 LPIN2	2.30e-05	199	127	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAT4 KIAA1549 WAC GANAB WIZ VCAN	2.30e-05	199	127	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN KIF26B ITGB5 TENM3 TENM1 TANC1	2.37e-05	200	127	6	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 NCKAP5 IFI16 BIRC6 BMPR2 SYNE2	2.37e-05	200	127	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MARK1 NCKAP5 PLEKHH3 AFAP1L2 SYNE2 TANC1	2.37e-05	200	127	6	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ABCA13 LAMA5 PLEKHH3 ARHGAP5 SRGAP3 SYNE2	2.37e-05	200	127	6	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN KIF26B ITGB5 TENM3 TENM1 TANC1	2.37e-05	200	127	6	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MARK1 NCKAP5 PLEKHH3 AFAP1L2 SYNE2 TANC1	2.37e-05	200	127	6	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 IL16 PDGFRA NHSL2 VCAN TENM1	2.37e-05	200	127	6	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN KIF26B ITGB5 TENM3 TENM1 TANC1	2.37e-05	200	127	6	347a510755374c6a66acee326565dfc447993f18
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXRA5 PDGFRA NCKAP5 VCAN MYO3B SYNE2	2.37e-05	200	127	6	3dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 IL16 PDGFRA NHSL2 ADGRG4 VCAN	2.37e-05	200	127	6	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MARK1 NCKAP5 PLEKHH3 AFAP1L2 SYNE2 TANC1	2.37e-05	200	127	6	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN KIF26B ITGB5 TENM3 TENM1 TANC1	2.37e-05	200	127	6	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXRA5 PDGFRA NCKAP5 VCAN MYO3B SYNE2	2.37e-05	200	127	6	ac8a5d71acd4d401995babd233f0d3738e8ad2a5
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 IL16 PDGFRA NHSL2 VCAN TENM1	2.37e-05	200	127	6	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Neuronal-Inhibitory-iB\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIF26B AKNA TENM3 TENM1 NHS TANC1	2.37e-05	200	127	6	45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 IL16 MXRA5 VCAN MYO3B TENM1	2.37e-05	200	127	6	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B PLEKHG4B SRGAP3 MYO3B MLPH	4.59e-05	137	127	5	48c21e6938a46e3cd74ac10b8ace0a4751741af7
ToppCell	remission-multiplets\|World / disease stage, cell group and cell class	ABCA13 DGKA IGSF10 KCNB1 KIAA2012	5.45e-05	142	127	5	286d01b4f95e9c0b38b91958f925f3797dffd596
Drug	2,4,6-triphenyl-1-hexene	CYP1A1 CYP1A2 UGT1A6	1.64e-06	5	126	3	ctd:C533342
Drug	1,7-phenanthroline	CYP1A1 CYP1A2 UGT1A6	9.08e-06	8	126	3	ctd:C053486
Drug	Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A	CYP1A1 MAGEA8 IL16 MXRA5 ATP10B F5 KIDINS220 VCAN	1.28e-05	194	126	8	4786_UP
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; HL60; HT_HG-U133A	TESK1 INO80D SBNO2 BMPR2 KIDINS220 WIZ PCIF1 HERC6	1.38e-05	196	126	8	2438_DN
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; PC3; HG-U133A	DGKA IFI16 INO80D SBNO2 WIZ TTLL4 LPIN2 MTRR	1.38e-05	196	126	8	1952_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	GALNT14 TPR WAC IFNGR1 BMPR2 SYNE2 TMPO MTRR	1.48e-05	198	126	8	4773_DN
Drug	Flurandrenolide [1524-88-5]; Down 200; 9.2uM; HL60; HT_HG-U133A	IFI16 F5 INO80D PCIF1 MTRR PRR14L HERC6 CEP97	1.48e-05	198	126	8	2184_DN
Drug	tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A	CYP1A1 F5 CALHM2 IFNGR1 SYNE2 PRR14L MTO1 NFAT5	1.54e-05	199	126	8	143_UP
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; PC3; HT_HG-U133A	GAK MAPK8IP3 IFNGR1 ARHGAP5 ALMS1 TTLL4 LPIN2 CABIN1	1.60e-05	200	126	8	6333_DN
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A	CYP1A2 FAT4 ZNF318 SBNO2 VCAN LPIN2 TMPO PRR14L	1.60e-05	200	126	8	5842_DN
Drug	2-methoxy-4-aminoazobenzene	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C053767
Drug	3,4,3',4'-tetrachloroazoxybenzene	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C013280
Drug	cloflucarban	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C005055
Drug	musk xylene	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C031447
Drug	sesamex	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C100180
Drug	Canthaxanthin	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:D016644
Drug	Pigment Yellow 74	CYP1A1 CYP1A2	3.04e-05	2	126	2	CID000022829
Drug	pyridoxal isonicotinoyl hydrazone	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C021079
Drug	nitroaniline	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C008625
Drug	7H-dibenzo(c,g)carbazole	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C013478
Drug	2,7-dinitrofluorene	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C085049
Drug	beta-apo-8'-carotenal	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C110652
Drug	propachlor	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C011088
Drug	allocryptopine	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C109505
Drug	2,7-FAA	CYP1A1 CYP1A2	3.04e-05	2	126	2	CID000009352
Drug	protopine	CYP1A1 CYP1A2	3.04e-05	2	126	2	ctd:C009093
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	GALNT14 SETD1B LAMA5 CALHM2 SBNO2 WIZ TMPO	6.81e-05	181	126	7	6951_DN
Drug	erucin	CYP1A1 CYP1A2 UGT1A6	7.17e-05	15	126	3	ctd:C073539
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	BMPR2 VCAN TMPO PRR14L IFI44L CABIN1 NFAT5	8.93e-05	189	126	7	5084_DN
Drug	2,3-diaminotoluene	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C100420
Drug	2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C522525
Drug	2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C519626
Drug	scutellarein	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C458179
Drug	genkwanin	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C014568
Drug	1-methoxyrutaecarpine	CYP1A1 CYP1A2	9.08e-05	3	126	2	CID005319487
Drug	Suppressor Factors, Immunologic	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:D013491
Drug	alyssin	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C524316
Drug	2-oxohexyl isothiocyanate	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C524315
Drug	Trichloroepoxypropane	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:D014239
Drug	3-aminofluorene	CYP1A1 CYP1A2	9.08e-05	3	126	2	CID000022818
Drug	1-aminofluorene	CYP1A1 CYP1A2	9.08e-05	3	126	2	CID000022817
Drug	2,2',4,6'-tetramethoxystilbene	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C541980
Drug	6-nitrobenzo(a)pyrene	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C034699
Drug	chlortoluron	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C007033
Drug	Aminoquinolines	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:D000634
Drug	7-(deoxyadenosin-N(6)--yl)aristolactam II	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C405699
Drug	1,2,3,7,8-pentachlorodibenzofuran	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C057584
Drug	7-nitrobenzanthracene	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C038954
Drug	1,2-dichloroethylene	CYP1A1 CYP1A2	9.08e-05	3	126	2	ctd:C035384
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	VGF ZNF318 ZNF106 ALMS1 SYNE2 LPIN2 PRKDC	9.54e-05	191	126	7	4168_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	VGF TPR CYP1A1 CYP1A2 CALHM2 PCIF1 PRR14L	1.02e-04	193	126	7	1652_UP
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	TPR CYP1A1 NDOR1 BMPR2 KIDINS220 PRR14L NFAT5	1.05e-04	194	126	7	4134_DN
Drug	AC1LC42M	A1BG CYP1A1 CYP1A2	1.06e-04	17	126	3	CID000547456
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	VGF CYP1A1 ATP10D MAPK8IP3 WIZ ALMS1 CEP97	1.09e-04	195	126	7	5447_DN
Drug	Harpagoside [19210-12-9]; Down 200; 8uM; HL60; HT_HG-U133A	PLPPR3 TESK1 SBNO2 BMPR2 WIZ ALMS1 TTLL4	1.12e-04	196	126	7	2935_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; HL60; HT_HG-U133A	TESK1 INO80D SBNO2 MAPK8IP3 BMPR2 KIDINS220 HERC6	1.12e-04	196	126	7	2424_DN
Drug	Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; PC3; HT_HG-U133A	THEMIS2 GALNT14 CYP1A1 IL16 INO80D SBNO2 ALMS1	1.16e-04	197	126	7	5106_UP
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A	PLPPR3 TESK1 F5 INO80D SBNO2 WIZ PCIF1	1.16e-04	197	126	7	2903_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; PC3; HT_HG-U133A	MARK1 SBNO2 MAPK8IP3 HPS6 PRR14L IFI44L CABIN1	1.19e-04	198	126	7	2107_UP
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A	VGF CYP1A1 ZNF318 TESK1 INO80D MAPK8IP3 CABIN1	1.19e-04	198	126	7	6472_DN
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HT_HG-U133A	GALNT14 CALHM2 VCAN IFI44L CABIN1 MUC6 CDH10	1.19e-04	198	126	7	6604_UP
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; HL60; HG-U133A	SETD1B TESK1 MAPK8IP3 ALMS1 TMPO MTO1 NFAT5	1.19e-04	198	126	7	1970_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A	RELN ZNF318 KCNB1 SRGAP3 VCAN TTLL4 MUC6	1.19e-04	198	126	7	6496_UP
Drug	Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	VGF CYP1A1 INO80D MAPK8IP3 ALMS1 HPS6 CABIN1	1.23e-04	199	126	7	6448_DN
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HT_HG-U133A	VGF GALNT14 CHAF1A KIDINS220 TENM3 TENM1 CABIN1	1.23e-04	199	126	7	6655_DN
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A	CASS4 CYP1A2 SETD1B F5 KIDINS220 WIZ VCAN	1.23e-04	199	126	7	2731_DN
Drug	Benzene	CYP1A1 CYP1A2 IL16 UGT1A6 AKNA TESK1 F5 ITGB5 IFNGR1 KIDINS220 VCAN HPS6 IFI44L PRKDC NFAT5	1.25e-04	892	126	15	ctd:D001554
Drug	Ascorbic acid [50-81-7]; Down 200; 22.4uM; HL60; HG-U133A	CYP1A2 SETD1B ANKRD27 CALHM2 MAPK8IP3 CABIN1 MLPH	1.27e-04	200	126	7	1610_DN
Drug	rutecarpine	CYP1A1 CYP1A2 BMPR2	1.27e-04	18	126	3	ctd:C028632
Drug	tectochrysin	CYP1A1 CYP1A2 UGT1A6	1.76e-04	20	126	3	CID005281954
Drug	1-chloropyrene	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C040345
Drug	purpurin	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C511975
Drug	2-nitrofluoranthene	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C049030
Drug	7-methoxyresorufin	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C076580
Drug	2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C520611
Drug	musk ketone	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C031448
Drug	3,6-dinitrobenzopyrene	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C068923
Drug	PY74	CYP1A1 CYP1A2	1.81e-04	4	126	2	CID000017893
Drug	N-methyl-7H-dibenzo(c,g)carbazole	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C041150
Drug	terbutryne	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C010347
Drug	thiacloprid	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C417209
Drug	5,5'-bis-trifluoromethyl-2,2'-dichlorobiphenyl	CYP1A1 CYP1A2	1.81e-04	4	126	2	CID000057528
Drug	1,2,3,5,6,7-hexachloronaphthalene	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C575652
Drug	KC 500	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C477388
Drug	3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C549241
Drug	3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C520945
Drug	tasquinimod	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C516109
Drug	3-hydroxyrutaecarpine	CYP1A1 CYP1A2	1.81e-04	4	126	2	CID000637395
Drug	sinensetin	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C059295
Drug	alpha-hederin	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C010177
Drug	4-aminofluorene	CYP1A1 CYP1A2	1.81e-04	4	126	2	CID000023488
Drug	Quinolinium Compounds	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:D011806
Drug	olivacine	CYP1A1 CYP1A2	1.81e-04	4	126	2	ctd:C011521
Drug	prochloraz	CYP1A1 MUC12 IFI16 HPS6 MLPH EIF2AK3	2.27e-04	155	126	6	CID000073665
Drug	TETs	A1BG BIRC6 TET1	2.36e-04	22	126	3	CID000064148
Drug	Quinine	CYP1A1 CYP1A2 SLC47A2	2.36e-04	22	126	3	ctd:D011803
Drug	MPB-PE	NHS FCAMR	3.01e-04	5	126	2	CID000124842
Drug	fluorene	CYP1A1 CYP1A2	3.01e-04	5	126	2	ctd:C041509
Drug	6-hydroxychrysene	CYP1A1 UGT1A6	3.01e-04	5	126	2	ctd:C087203
Drug	1,2,3,4,6,7-hexachlorinated naphthalene	CYP1A1 CYP1A2	3.01e-04	5	126	2	ctd:C412791
Disease	plasma clozapine measurement	CYP1A1 CYP1A2 UGT1A6	3.62e-06	8	120	3	EFO_0600038
Disease	plasma N-desmethylclozapine measurement	CYP1A1 CYP1A2 UGT1A6	1.06e-05	11	120	3	EFO_0600039
Disease	Van Maldergem Wetzburger Verloes syndrome	FAT4 DCHS1	1.64e-05	2	120	2	C1832390
Disease	5-hydroxy-2-methylpyridine sulfate measurement	CYP1A1 CYP1A2	1.64e-05	2	120	2	EFO_0801051
Disease	Van Maldergem syndrome	FAT4 DCHS1	1.64e-05	2	120	2	cv:C1832390
Disease	1-stearoylglycerol 1-monostearin measurement	KIAA1549 SYNE2	1.64e-05	2	120	2	EFO_0021111
Disease	serum clozapine measurement	CYP1A1 CYP1A2	1.64e-05	2	120	2	EFO_0600041
Disease	hypereosinophilic syndrome (is_implicated_in)	PDGFRA F5	1.64e-05	2	120	2	DOID:999 (is_implicated_in)
Disease	Periventricular gray matter heterotopia	FAT4 DCHS1	1.64e-05	2	120	2	C1849173
Disease	progressive familial intrahepatic cholestasis (implicated_via_orthology)	ATP10B ATP10D	4.91e-05	3	120	2	DOID:0070221 (implicated_via_orthology)
Disease	glycosyl ceramide (d16:1/24:1, d18:1/22:1) measurement	ATP10D SYNE2	4.91e-05	3	120	2	EFO_0800530
Disease	Heterotopia, Periventricular, Autosomal Recessive	FAT4 DCHS1	4.91e-05	3	120	2	C1842563
Disease	heart septal defect (is_implicated_in)	BMPR2 MTRR	9.79e-05	4	120	2	DOID:1681 (is_implicated_in)
Disease	X-21286 measurement	CYP1A1 CYP1A2	9.79e-05	4	120	2	EFO_0800804
Disease	Malignant neoplasm of breast	THEMIS2 CYP1A1 LRRC37A2 ZNF318 TESK1 SGK3 PPP1R3A BMPR2 SRGAP3 SYNE2 TENM1 SLC39A6 NHS CDH10	1.22e-04	1074	120	14	C0006142
Disease	porphyria cutanea tarda (is_implicated_in)	CYP1A1 CYP1A2	2.43e-04	6	120	2	DOID:3132 (is_implicated_in)
Disease	cystatin C measurement	CYP1A1 CYP1A2 NBAS BMPR2 ALMS1 TANC1 NFAT5 KIAA2012	2.47e-04	402	120	8	EFO_0004617
Disease	Pilomyxoid astrocytoma	KIAA1549 SRGAP3	3.40e-04	7	120	2	C1519086
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	ATP10D SYNE2	3.40e-04	7	120	2	EFO_0800551
Disease	2-aminooctanoate measurement	LDHD ALMS1	4.52e-04	8	120	2	EFO_0800349
Disease	advanced glycation end-product measurement	CYP1A1 CYP1A2	5.80e-04	9	120	2	EFO_0007819
Disease	4-vinylphenol sulfate measurement	SGK3 ARSL	7.23e-04	10	120	2	EFO_0021149
Disease	theophylline measurement	CYP1A1 CYP1A2	7.23e-04	10	120	2	EFO_0021180
Disease	sweet beverage consumption measurement	CYP1A1 CYP1A2	7.23e-04	10	120	2	EFO_0010090
Disease	2-ketocaprylate measurement	LDHD ALMS1	7.23e-04	10	120	2	EFO_0800110
Disease	1,7-dimethylurate measurement	CYP1A1 CYP1A2	7.23e-04	10	120	2	EFO_0021512
Disease	Nephroblastoma	NBAS NHS	7.23e-04	10	120	2	Orphanet_654
Disease	age at onset, multiple sclerosis	RELN NCKAP5	7.23e-04	10	120	2	EFO_0004847, MONDO_0005301
Disease	1-methylxanthine measurement	CYP1A1 CYP1A2	8.81e-04	11	120	2	EFO_0021174
Disease	5-acetylamino-6-amino-3-methyluracil measurement	CYP1A1 CYP1A2	8.81e-04	11	120	2	EFO_0800951
Disease	Male sterility	CYP1A1 NSUN7 MTRR	9.93e-04	48	120	3	C0917731
Disease	Male infertility	CYP1A1 NSUN7 MTRR	9.93e-04	48	120	3	C0021364
Disease	Subfertility, Male	CYP1A1 NSUN7 MTRR	9.93e-04	48	120	3	C0848676
Disease	paraxanthine measurement	CYP1A1 CYP1A2	1.05e-03	12	120	2	EFO_0021178
Disease	N-acetyl-2-aminooctanoate measurement	LDHD ALMS1	1.05e-03	12	120	2	EFO_0800567
Disease	Hepatomegaly	A1BG CYP1A1 CYP1A2	1.40e-03	54	120	3	C0019209
Disease	lobe attachment	FAT4 PDGFRA TTLL4 MYO3B PRKDC	1.61e-03	207	120	5	EFO_0007667
Disease	1,3,7-trimethylurate measurement	CYP1A1 CYP1A2	1.66e-03	15	120	2	EFO_0021172
Disease	coffee consumption, cups of coffee per day measurement	CYP1A1 CYP1A2	1.90e-03	16	120	2	EFO_0004330, EFO_0006782
Disease	tea consumption measurement	CYP1A1 CYP1A2 PLEKHH3 NFAT5	1.94e-03	129	120	4	EFO_0010091
Disease	blood lead measurement	KCNB1 SRGAP3 TANC1	2.49e-03	66	120	3	EFO_0007040
Disease	caffeine metabolite measurement	CYP1A1 CYP1A2	2.68e-03	19	120	2	EFO_0007872
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	MADD ZNF106 SYNE2 PCIF1	2.88e-03	144	120	4	EFO_0004611, EFO_0020943
Disease	Contact Dermatitis	CYP1A1 UGT1A6 PRDX6	3.07e-03	71	120	3	C0011616
Disease	Contact hypersensitivity	CYP1A1 UGT1A6 PRDX6	3.07e-03	71	120	3	C0162351
Disease	Lung Injury	CYP1A1 CYP1A2	3.27e-03	21	120	2	C0273115
Disease	Chronic Lung Injury	CYP1A1 CYP1A2	3.27e-03	21	120	2	C2350344
Disease	Schizophrenia	A1BG CYP1A2 RELN ABCA13 CLOCK PRDX6 SBNO2 KCNB1 SRGAP3 TET1	3.29e-03	883	120	10	C0036341
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	RELN PPP1R3A MST1R TET1 NFAT5 KIAA2012	3.80e-03	364	120	6	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	body fat percentage	RELN PPP1R3A MST1R SRGAP3 TET1 NFAT5 KIAA2012	3.88e-03	488	120	7	EFO_0007800

Protein segments in the cluster

Peptide	Gene	Start	Entry
SIHDLPLFTETSPTS	AAAS	511	Q9NRG9
LSRDPSETHILTPAS	ARSL	516	P51690
TLPFHVLRSLFSTTP	BIRC6	4211	Q9NR09
TSFAEESRPHALPSS	CASS4	261	Q9NQ75
STTPFPSQHRTEIEL	VCAN	641	P13611
NRSHISETPLDSESP	CRYBG3	616	Q68DQ2
HSPSRTPVLVGSDEF	EIF2AK3	436	Q9NZJ5
LTETPFHSLRLSTPV	ADGRG4	1106	Q8IZF6
SPISPHFTVTERQTF	ACRBP	151	Q8NEB7
HDLPQIPASRFTSTA	FAT4	2021	Q6V0I7
PLERSDFTGSHSEPS	ALMS1	2811	Q8TCU4
TTVDTTHLENVSPRP	AFAP1L2	756	Q8N4X5
FEHITAETPSRPLSS	SPECC1	331	Q5M775
SSIVPSFHSLPSLTE	ABCA13	751	Q86UQ4
VAPDHFASSLASRVP	BSX	36	Q3C1V8
PFSTDTLSSHPLSEA	ANKIB1	931	Q9P2G1
RTEASRTHPSPFLAL	C1orf147	26	Q96MC9
PEEDSVLSHSSLSSP	CHAF1A	276	Q13111
ALESNPSDHPRASTI	CCNYL1	76	Q8N7R7
PSDHPRASTIFLSKS	CCNYL1	81	Q8N7R7
HRESSQPPVAFSSSI	ATP10B	526	O94823
SEVPHSRQAAFSSPI	ATP10D	531	Q9P241
FVPFTIPHSTTRDTS	CYP1A1	381	P04798
FLPFTIPHSTTRDTT	CYP1A2	381	P05177
ALAFSRTHSPLLSTP	KIAA1549	351	Q9HCM3
RTHSPLLSTPLAFAS	KIAA1549	356	Q9HCM3
LVPRSSTSPDRIFFH	A1BG	251	P04217
PSVVTPFSRDDRGHT	ANKRD27	451	Q96NW4
RTTDPETPVTLHNSE	PDGFRA	151	P16234
FPHSEITTLRSRTPG	MUC16	5601	Q8WXI7
SPVTQRFPHSEETTT	MUC16	5891	Q8WXI7
SHSSPLRVTSLFTPV	MUC16	8876	Q8WXI7
TTIRATLPHTISSPF	MUC6	2206	Q6W4X9
HSPRLSEDPTFLAVA	DCHS1	1101	Q96JQ0
SHVVPEDPRFLSESS	KIDINS220	1281	Q9ULH0
RHPSSDSVAQTPELL	MADD	21	Q8WXG6
STSPDPAHLESLFRE	MAGEA8	96	P43361
TATLRPGPLTEHVFT	MAPK8IP3	911	Q9UPT6
IPEPTTETRHSTALE	LRRC37A2	756	A6NM11
CPERSHISDQSPLSS	TMPO	341	P42166
SESEHLPARDSPSLS	LSG1	281	Q9H089
SSDSAAPRTPHFDVI	MTO1	26	Q9Y2Z2
PEHSTFITSPSLKDR	IFI44L	301	Q53G44
RATVDPDFPIAHLSS	KIF26B	836	Q2KJY2
LSEHPLLSEPSSVSF	KIAA1109	2336	Q2LD37
SISPRTTNSFHLPDD	MTRR	521	Q9UBK8
RLFPSLSITTELTHP	KCNT1	891	Q5JUK3
VDPSSLTAREEHFPS	CALHM2	136	Q9HA72
PETFSERDHPTSITC	HERC6	971	Q8IVU3
DVDISTHSPSLPLAR	IL16	536	Q14005
STSEALRIDPVPNTH	DGKA	361	P23743
TVHLPVDASRDTLSP	KIAA2012	476	Q0VF49
SPEFVEPRVSCISSH	LAMA5	1196	O15230
VTSHETSDFFPRPLR	MIER3	131	Q7Z3K6
SPASSFHVLRSLPLS	ITGB5	81	P18084
RLAILSNFPETTSPH	NBAS	756	A2RRP1
FSSTEPTVHTRPDNL	NFAT5	846	O94916
PRAFSIASSLLTHPS	NDOR1	381	Q9UHB4
LDTFSSAPVPQHERS	RELN	2671	P78509
AIPTRAITADVSHSP	PPP1R3A	571	Q16821
PPTSIIITFHNEARS	GALNT14	111	Q96FL9
PPSSSADASRFLHTL	GAK	781	O14976
TFPEDESSSRTLAPV	FCAMR	441	Q8WWV6
FPASPTREAHRESSV	FBF1	356	Q8TES7
IIRHSTIPPFLSSSA	IGSF10	1456	Q6WRI0
TDFPEATRFSHSPLT	KCNB1	596	Q14721
RSEKNHFESSPLPTS	KCNB1	791	Q14721
ATTSFPLHSPGLLET	CABIN1	346	Q9Y6J0
SHFERLLESSPEPLS	PCIF1	566	Q9H4Z3
SREAPNPIHLTVDTS	EIF3F	191	O00303
PDSISSPIRFSLDRH	CDH10	411	Q9Y6N8
TRASLIPEHSSPVQD	CEP97	321	Q8IW35
TATTLRLHPAPEATV	LDHD	256	Q86WU2
TTPLSPPHSFNRDET	BMPR2	136	Q13873
HSEVNPSVELSPARS	AKNA	186	Q7Z591
EASTTFPESHLRTPQ	IFI16	416	Q16666
AHSISTATPDRTRFP	MARK1	591	Q9P0L2
VEASHIRSPSTPELS	INO80D	581	Q53TQ3
PRFHDTSSPLLISGT	EPS15	101	P42566
LRGTPETPTSHFAVS	FCRLB	401	Q6BAA4
LTEPTLALSAESHRP	C1orf127	626	Q8N9H9
LTPEELRHSSTFRAP	HPS6	421	Q86YV9
ESCPSVSIPSSDEHR	SGK3	11	Q96BR1
LAPVPTHSTVSELSR	DUSP5	361	Q16690
VPGSHLTPIERESSS	IFNGR1	366	P15260
SLHLSSVPEARDSPQ	MLPH	211	Q9BV36
TTESSRTFPEHCAPA	PRR14L	1731	Q5THK1
SDVSEEPVPHRTITS	RUSC1	301	Q9BVN2
PSTTPSPDSELHRVF	SPATA48	386	A4D263
SLSRPGETEPIHSVS	PLEKHH3	691	Q7Z736
TETVRSQTHSLPAPE	VGF	116	O15240
PEEAHALSAPTSRLS	SLC47A2	556	Q86VL8
SVLDRLPQPAESSTH	SYNE2	5451	Q8WXH0
ISPDLSHTTLSPDLS	F5	1231	P12259
RPADSAIVHSTSDPI	NCKAP5	1781	O14513
TTSDIRPSHSVPEGV	NHSL2	311	Q5HYW2
HFLTFNSTRSPSPTE	NHS	281	Q6T4R5
CVHFLTATPDPSRSV	SCRN2	301	Q96FV2
SCIFPSTTIPDHLSS	NSUN7	111	Q8NE18
PESRLSFQHDPETSV	GANAB	911	Q14697
LFSHPRDFTPVCTTE	PRDX6	36	P30041
TSDPTQDLHFTPLLS	TANC1	451	Q9C0D5
STHVIPPEVSFDSRR	TENM1	871	Q9UKZ4
HPDRVVETSTLSSVP	SBNO2	216	Q9Y2G9
FPSTHDPRTVTLDFR	SETD1B	1561	Q9UPS6
DYRLPRAETHSSSTP	WAC	231	Q9BTA9
SSLEARSPSDLHISP	WIZ	1121	O95785
ESTHQSEDVFLPSPR	ARHGAP5	956	Q13017
SEVHPSLERATPQTS	SEBOX	156	Q9HB31
PHIDEFFTLNSTPSR	MSANTD4	181	Q8NCY6
NPSRPSSSELVELHV	SPATA1	26	Q5VX52
SEGTHFLETIETPRP	SLC39A6	196	Q13433
SHETPLPESALTLRN	TET1	1341	Q8NFU7
LERFDHSPTPSASSR	CLOCK	421	O15516
TPSSFSVELPSNRHI	C12orf40	151	Q86WS4
VLDEASHQRTPAPSS	SPEM2	406	Q0P670
SSEPASPLHTIVIRD	SRGAP3	1006	O43295
VTFSHTLPRASAPSL	PLPPR3	371	Q6T4P5
STPTLVVPHRTDGFA	TPR	2136	P12270
AAPFKRPHSTISDSS	PLEKHG4B	1181	Q96PX9
DTSHPTDPLTSFLGL	THEMIS2	461	Q5TEJ8
LSTFFRSSPEDSPII	TENM3	971	Q9P273
LEPSTRAPFTEITQH	TESK1	296	Q15569
PLVDHTSPSSDSLLF	PRKDC	2666	P78527
CSLEHTFSRSPDPVS	UGT1A6	176	P19224
EVNISPSLHSSSPLD	TTLL4	906	Q14679
HSELERSFLSEPSSP	VIRMA	1566	Q69YN4
PASVTDDPSALHTRL	MST1R	266	Q04912
PVDFCTTRVSPAHRS	ZNF318	2021	Q5VUA4
ARLSLPESTESFHEP	ZNF106	1246	Q9H2Y7
DHFRPAILTSRESPT	ZNF181	136	Q2M3W8
TRPSTSHFSVLSFTP	SIGLEC16	191	A6NMB1
LSPDRSAEVSNSIHP	INSYN2B	221	A6NMK8
TFHSSPGDTETTLLP	MUC12	1526	Q9UKN1
SVRGEEPTTFHSRPA	MUC12	2406	Q9UKN1
VRGEEPTTFHSRPAS	MUC12	2881	Q9UKN1
TFHSSPGDTETTLLP	MUC12	4166	Q9UKN1
TPSENTHFRVIPSED	LPIN2	291	Q92539
PSEVHCTFRSLASVP	MXRA5	36	Q9NR99
ARITVASSSLPPHFS	MYO3B	891	Q8WXR4